Book a demo
VirnetX & Leidos v. Mangrove Partners & Apple — Secure Communications Patent | PatSnap
Explore in Eureka
Case ID23-315
FiledSep 2023
ClosedFeb 2024
Patent Litigation

VirnetX & Leidos v. Mangrove Partners & Apple — Supreme Court Petition Denied

VirnetX and Leidos brought four secure-communications patents to the U.S. Supreme Court after adverse IPR outcomes, naming Apple, Mangrove Partners, and the USPTO Director as respondents. The Court denied the petition in 153 days, closing off the federal appellate path for these patents.

Resolution time
153days
153 days — resolved in under 6 months at the Supreme Court level
Patents asserted
4
US7921211B2 and 3 further patents asserted — secure VPN and domain name tech
Outcome
Petition Dismissed
Supreme Court declined review — IPR outcomes against VirnetX patents stand
Cost ruling
N/A
No costs ruling recorded in the public docket for this petition
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

Supreme Court closes the door on VirnetX’s IPR appeal campaign

VirnetX, Inc. and Leidos, Inc. filed a petition for certiorari with the U.S. Supreme Court on 20 September 2023, docketed as Case No. 23-315. The petition challenged inter partes review (IPR) decisions that had invalidated claims across four VirnetX patents — US7921211B2, US7490151B2, US6502135B1, and US7418504B2 — covering secure domain-name and VPN technologies. The respondents included Mangrove Partners Master Fund, Apple Inc., Black Swamp IP, and the USPTO Director.

The Supreme Court denied the petition on 20 February 2024, just 153 days after filing. A denial of certiorari does not constitute a ruling on the merits, but it leaves the lower tribunal decisions — and the IPR invalidations of the asserted patent claims — in place. For VirnetX and Leidos, this effectively exhausts the appellate avenue for the challenged claims, absent extraordinary procedural grounds.

The 153-day resolution is consistent with the Supreme Court’s standard certiorari cycle, which typically concludes within one term. The denial suggests the Court did not find a circuit split, constitutional question, or issue of sufficient national importance to warrant review. The public record does not disclose whether any settlement or licensing agreement accompanied the petition’s withdrawal consideration, and the basis of termination — petition dismissed — reflects a clean procedural close.

Case at a glance
Case no.23-315
PlaintiffVirnetX, Inc.
CourtU.S. Supreme
Judge/
FiledSeptember 20, 2023
ClosedFebruary 20, 2024
Duration153 days
OutcomePetition Dismissed
Verdict causeInfringement Action
BasisPetition Dismissed
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / U.S. Supreme Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to dismissal in 153 days

153 days — resolved in under 6 months at the Supreme Court level

Case timeline: Complaint filed May 13 2025, DEC–JAN — 153 days total Horizontal timeline showing the three key events in VirnetX, Inc. v Mangrove Partners Master Fund, Ltd. from filing to voluntary dismissal. Source: PACER, U.S. Supreme Court. SEP 20 2023 Complaint filed DEC–JAN 2023 Pre-trial proceedings FEB 20 2024 Dismissed with prejudice 153 DAYS TOTAL
Court ruling

What a denied certiorari petition means for VirnetX’s patent portfolio

Legal mechanism

Certiorari denial leaves IPR invalidations intact

When the Supreme Court denies certiorari, it declines to hear the case on the merits. It does not affirm the lower decision, but it leaves it standing. Here, the IPR decisions cancelling claims of the four VirnetX patents remain in full effect. VirnetX cannot relitigate those same claim-validity questions in federal court through this avenue.

IPR finality confirmed
Dismissal basis

Petition dismissed — not decided on the merits

The docket records the basis of termination as ‘Petition Dismissed’, consistent with a certiorari denial. This is a procedural close, not a substantive ruling on whether the patents were validly invalidated. The distinction matters: VirnetX retains any patents not subject to the IPR proceedings, and the denial does not create binding precedent on the underlying patent law questions raised.

Procedural close, no merits ruling
Patent portfolio impact

Four core VirnetX patents lose their last appellate shield

The four patents — covering secure domain name services and VPN-on-demand architecture — had been central to VirnetX’s licensing and enforcement programme against Apple’s FaceTime and VPN on Demand products. With certiorari denied, the cancelled claims can no longer be enforced, materially narrowing VirnetX’s leverage in any ongoing or future licensing negotiations involving these specific claim sets.

Enforcement leverage reduced
Competitive implications

Apple and Mangrove Partners’ IPR strategy validated

Mangrove Partners’ use of inter partes review as a defensive tool against VirnetX’s patent assertions — and Apple’s alignment with that strategy — proved effective through every appellate tier. The outcome is consistent with a broader pattern of hedge-fund-backed IPR petitions successfully neutralising NPE patent portfolios. It suggests the IPR route remains a viable, cost-efficient counter to serial patent assertion.

IPR as NPE defence — confirmed
Legal analysis based on PACER docket records for case 23-315 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffVirnetX, Inc.CompanyPatent licensing entity and Leidos, Inc. — holders of four secure VPN and domain name patentsSearch in Eureka ↗
DefendantMangrove Partners Master Fund, Ltd.CompanyMangrove Partners Master Fund, hedge fund IPR petitioner; Apple Inc., FaceTime and VPN on Demand developerSearch in Eureka ↗
Plaintiff counselNaveen ModiAttorneyCounsel for VirnetX, Inc.Search in Eureka ↗
Defendant counselJames T. BaileyAttorneyCounsel for Mangrove Partners Master Fund, Ltd.Search in Eureka ↗
Presiding judgeJudge /Chief JudgeU.S. Supreme Court — Chief JudgeSearch in Eureka ↗
Official verdict

Stipulation of dismissal — official text

“Petition DENIED.”
Source: PACER Docket, Case 23-315, U.S. Supreme Court · Filed February 20, 2024

The Supreme Court’s one-word disposition — ‘Petition DENIED’ — is procedurally significant but substantively neutral. The Court does not explain denials, so no inference can be drawn about the merits of VirnetX’s arguments. What is certain: the Federal Circuit and PTAB rulings that cancelled the asserted claims now represent the final word. Both Apple and Mangrove Partners can rely on those decisions as settled authority.

PACER case 23-315 · Public docket record Explore in Eureka ↗
Patent at issue

US7921211B2 and three further patents — secure VPN and domain name technology

Publication No.US7921211B2
Application No.US11/840560
Patent details
AssigneeVirnetX, Inc.
ProductUS7921211B2 — secure domain name and VPN communication system
Publication typeB2 — grant (with prior publication)
Cited in actionSeptember 20, 2023

Publication No.US7490151B2
Application No.US10/259494
Patent details
AssigneeVirnetX, Inc.
ProductUS7490151B2 — secure domain name services for communications
Publication typeB2 — grant (with prior publication)
Cited in actionSeptember 20, 2023

Publication No.US6502135B1
Application No.US09/504783
Patent details
AssigneeVirnetX, Inc.
ProductUS6502135B1 — agile network protocol for secure communications
Publication typeB2 — grant (with prior publication)
Cited in actionSeptember 20, 2023

Publication No.US7418504B2
Application No.US10/714849
Patent details
AssigneeVirnetX, Inc.
ProductUS7418504B2 — agile network protocol, VPN on Demand
Publication typeB2 — grant (with prior publication)
Cited in actionSeptember 20, 2023

The four patents at the centre of this petition cover foundational aspects of secure network communications: establishing virtual private network tunnels, secure domain name lookups, and on-demand VPN provisioning. US6502135B1, the earliest in the family, originates from application US09/504783 and covers the core agile network protocol for secure communications. The later grants extend these concepts to domain name services and VPN-on-demand architectures that map closely to modern mobile and enterprise secure-communication implementations.

These patents had been the basis of VirnetX’s multi-year enforcement campaign against Apple, generating significant royalty awards at the district court level before IPR proceedings cancelled the key claims. The technology domain — secure tunnelling and domain name privacy — remains commercially active, and the underlying concepts are embedded in products far beyond Apple’s ecosystem. The invalidation of these specific claim sets opens design space, but does not eliminate all IP risk in the secure communications layer.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should your team run an FTO against the VirnetX patent family?

Any R&D or product team building secure communications features — VPN clients, encrypted domain name resolution, or on-demand tunnel provisioning — should assess residual VirnetX portfolio exposure. While the four patents in this case have had key claims cancelled via IPR, VirnetX and Leidos may hold related patents or continuations not addressed by these proceedings. Assuming freedom-to-operate based solely on this Supreme Court outcome would be premature.

PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the full VirnetX patent family, identifying which claims remain active and which have been cancelled. Claim monitoring alerts will flag any new continuation filings or reissue applications that could reintroduce blocking positions. For teams in the secure networking or VPN space, this kind of ongoing landscape monitoring is more efficient than point-in-time legal opinions alone.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7921211B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Supreme Court patent petitions in secure communications and VPN tech

PatSnap Eureka tracks related litigation across truck body equipment, vehicle accessories, and comparable infringement actions in the Georgia district system.

🔍
Access 40+ similar cases in PatSnap Eureka
VirnetX, Inc. patent enforcement history, U.S. Supreme case history, VirnetX, Inc.’s full IP portfolio, and comparable case analysis
VirnetX v. Apple (E.D. Tex.)Uniloc v. Apple cert. denialStraight Path v. Apple VoIPMangrove IPR petition history
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the secure communications IP landscape

The denial closes a major NPE enforcement campaign in secure networking. Here is what IP teams should take away.

IPR remains the most effective tool against NPE patent portfolios

The VirnetX litigation arc — spanning district courts, the Federal Circuit, and now the Supreme Court — illustrates that a well-executed IPR petition can neutralise even heavily litigated NPE patents. Companies facing assertion in the secure communications or VPN space should prioritise IPR petitioning over purely defensive district court strategies.

FaceTime and VPN on Demand cleared of these specific patent claims

With the certiorari petition denied, Apple’s FaceTime and VPN on Demand products face no further liability under the four invalidated patent claim sets. Product teams and licensing counsel at companies building on similar secure-communication architectures should note that these specific claim sets no longer represent enforceable blocking positions.

🔒
Full strategic analysis in PatSnap Eureka
Includes sector IP trends, Judge Treadwell’s case history, and FTO risk assessment for the truck equipment space
Hedge fund IPR patternsResidual VirnetX exposureSecure VPN claim mapping
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

VirnetX v Mangrove — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Run your own FTO analysis on secure communications patents

Use PatSnap Eureka to map residual VirnetX patent exposure, track IPR-cancelled claim status, and monitor new filings in the secure VPN and domain name technology space before they become litigation risk.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.